ABSTRACT
BACKGROUND: Optimal treatment of prostate cancer depends on accurate staging. Computed tomography (CT) and magnetic resonance imaging have severe limitations, and standard bone scanning can show only destructive osseous metastases. A radiolabeled antibody specific to prostatic adenocarcinoma could theoretically find evidence of soft-tissue metastases and lymph node involvement. METHODS: An immunoconjugate (CYT-356) consisting of a murine monoclonal antibody against human prostatic adenocarcinoma bound to a linker-chelator and radiolabeled with indium 111 was administered intravenously to seven patients with documented Stage D adenocarcinoma of the prostate. Planar imaging was done on days 1, 2, and 3 after injection. The CYT-356 scans were compared with standard technetium Tc99m sulfur colloid bone scans and CT scans. RESULTS: Optimal imaging results were obtained on the 72-h scans. All patients had lesions on both the 99mTc-sulfur colloid bone scan and the CYT-356 scan. The location of the lesions correlated to a great extent. Two patients had positive lesions biopsied, and both biopsies showed the presence of metastatic prostatic carcinoma. There were no side effects from administration of the antibody. CONCLUSION: In this preliminary study, CYT-356 scanning appears to be a promising agent to accomplish specific staging of prostatic carcinoma.
Subject(s)
Adenocarcinoma/diagnostic imaging , Bone Neoplasms/diagnostic imaging , Indium Radioisotopes , Prostatic Neoplasms/diagnostic imaging , Radioimmunodetection , Technetium Tc 99m Sulfur Colloid , Adenocarcinoma/secondary , Antibodies, Monoclonal , Bone Neoplasms/secondary , Humans , Injections, Intravenous , Male , Prostatic Neoplasms/pathology , Reproducibility of ResultsABSTRACT
Estimates of the 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) body-burden acquired from an environment in which 2,3,7,8-TCDD has been introduced in a high concentration, are derived from an idealized linear reaction kinetic model. The model parameters are the 2,3,7,8-TCDD transfer factor from the environmental soil medium to the human body, the background intake, the soil concentration and the body and soil elimination half-times. Values of the transfer factor are estimated from reported human and environmental data. The model conservatively determines a time-scale over which the acquired body-burden may be significantly higher than the background dose caused by the ubiquitous presence of 2,3,7,8-TCDD in food, consumer products, etc. and allows comparison of the cumulative body-burden with published values for the minimum toxic dose and derived values of the minimum guideline dose. The linear nature of the model also provides a framework for the estimation of the 2,3,7,8-TCDD toxic equivalent (TEQ) body-burden acquired from environments in which a mixture of polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs) are present.
Subject(s)
Polychlorinated Dibenzodioxins/pharmacokinetics , Body Burden , Child , Half-Life , Humans , Mathematics , Models, Biological , Polychlorinated Dibenzodioxins/toxicity , Soil Pollutants/toxicityABSTRACT
We report 2 cases of self-inflicted penile amputations, which offered differing surgical options and contrasting surgical results due to varying time delays. In 1 case repair was done immediately, while repair in the other case was delayed by 3 days due to the psychotic state of the patient. The psychiatric backgrounds of such episodes are discussed, as well as the techniques of repair and reconstruction.
Subject(s)
Penis/injuries , Psychotic Disorders , Self Mutilation , Adult , Humans , Male , Penis/surgery , Replantation , Scrotum/injuries , Surgery, Plastic , Time FactorsABSTRACT
The small bowel may be subjected to transient, yet reversible ischemia in situations such as volvulus, thromboembolism, and low flow states. The surgeon is frequently faced with the necessity of intestinal resection in treating such cases. The remaining bowel, while judged viable may have been exposed to significant ischemic injury. The surgeon must decide whether such bowel will heal satisfactorily if used in an anastomosis. This study was undertaken to determine the effect of transient ischemia on intestinal anastomotic healing in the rat. Male albino rats were subjected to superior mesenteric artery occlusion for periods of 30 minutes or 45 minutes. The circulation was then re-established. The small bowel was the transected and anastomosed. Animals in each group were sacrificed at 7 and 10 days and bursting pressures performed to test the healing of the anastomosis. Results were compared with a control group having an anastomosis without precedent ischemia. There were no significant differences among the groups. The data clearly indicate that if the bowel remains viable following an ischemic insult its healing is unimpaired.
